Results 171 to 180 of about 265,465 (283)
Use of Thrombectomy in the Treatment of Acute Iliofemoral Venous Thrombosis in Forty-five Patients
Julia A. Haller, Berel L. Abrams
openalex +2 more sources
Abstract Aims Describe patient characteristics, treatment patterns, clinical outcomes, healthcare resource utilization (HCRU) and medical costs associated with patients who were diagnosed with obstructive hypertrophic cardiomyopathy (HCM) in clinical practice in England.
Faizel Osman+9 more
wiley +1 more source
Prophylaxis of venous thrombosis and pulmonary embolism in patients with acute traumatic spinal cord lesions [PDF]
E Rocha Casas+3 more
openalex +1 more source
Abstract Background Heart failure (HF) is a risk factor for ischemic stroke. Cognitive impairment is very common in HF and stroke patients. Patients with HF have higher risk of developing dementia. However, there are limited studies investigating the characteristics, in‐hospital mortality and complications of stroke patients with both HF and dementia ...
Lijun Zuo+6 more
wiley +1 more source
Abstract LncRNA UCA1 plays a vital role in cardiovascular diseases. Endothelial cell dysfunction is a prerequisite for atherosclerosis (AS) development. However, the pathophysiological role of UCA1 in endothelial cell dysfunction induced by ox‐LDL remains obscure.
Shu‐Xin Zhang, Cheng‐Hong Yu
wiley +1 more source
Secondary sclerosing cholangitis in patients suffering cardiogenic shock
Abstract Aims Cardiogenic shock (CS) patients suffer from severe organ hypoperfusion, yet the incidence of secondary sclerosing cholangitis in critically ill patients (SSC‐CIP) in CS is poorly described. Given the limited evidence and severity of this syndrome, we aimed to further investigate SSC‐CIP in the context of CS.
Hugo Lanz+25 more
wiley +1 more source
In the context of patients with severe heart failure, it is crucial to ensure adequate preconditioning before considering the implantation of dLVAD. Although several types of mechanical circulatory assist devices are available and all offer a significant advantage, the present study suggests that the higher the flow rate provided by the Impella®, the ...
Marta L. Medina+32 more
wiley +1 more source
Screened Fibrinogen for Prophylaxis of Venous Thrombosis [PDF]
N. C. Allan+3 more
openalex +1 more source
Endovascular treatment for cerebral venous thrombosis: a multicenter study in China. [PDF]
Bian HT+41 more
europepmc +1 more source